SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-000287
Filing Date
2020-01-02
Accepted
2020-01-02 16:18:04
Documents
2
Period of Report
2020-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 8318
2 POA DOCUMENT poa.txt EX-24.3_885621 4511
  Complete submission text file 0001209191-20-000287.txt   14243
Mailing Address C/O AEGERION PHARMACEUTICALS, INC. 101 MAIN STREET, SUITE 1850 CAMBRIDGE MA 02142
Business Address
Rothera Mark (Reporting) CIK: 0001550424 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38722 | Film No.: 20501754

Mailing Address 108 CANNON STREET LONDON X0 EC4N 6EU
Business Address 108 CANNON STREET LONDON X0 EC4N 6EU 011-44-0-203-3846700
Orchard Therapeutics plc (Issuer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000
SIC: 2836 Biological Products, (No Diagnostic Substances)